Cannonau Corp
Cannonau Corp. engages in the provision of cannabidiol based products. The company was formerly known as Pacific Blue Energy Corp. and changed its name to Cannonau Corp. in August 2019. Cannonau Corp. was incorporated in 2007 and is based in Skaneateles, New York.
Cannonau Corp (CNNC) - Net Assets
Latest net assets as of March 2024: $0.00 USD
Based on the latest financial reports, Cannonau Corp (CNNC) has net assets worth $0.00 USD as of March 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($0.00) and total liabilities ($0.00). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $0.00 |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Cannonau Corp - Net Assets Trend (2008–2023)
This chart illustrates how Cannonau Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cannonau Corp (2008–2023)
The table below shows the annual net assets of Cannonau Corp from 2008 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $0.00 | -- |
| 2022-12-31 | $-338.24K | -34.07% |
| 2021-12-31 | $-252.29K | -69.52% |
| 2020-12-31 | $-148.82K | -90.12% |
| 2019-12-31 | $-78.28K | -1018.27% |
| 2018-12-31 | $-7.00K | 0.00% |
| 2017-12-31 | $-7.00K | 0.00% |
| 2016-12-31 | $-7.00K | -100.55% |
| 2010-12-31 | $1.27 Million | +5254.83% |
| 2009-12-31 | $-24.65K | -363.59% |
| 2008-12-31 | $-5.32K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cannonau Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 340851500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $241.81K | % |
| Other Comprehensive Income | $27.00K | % |
| Other Components | $3.15 Million | % |
| Total Equity | $-27.00K | 100.00% |
Cannonau Corp Competitors by Market Cap
The table below lists competitors of Cannonau Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
FIRST PACIFIC
MU:FPC
|
$6.54K |
|
Enigma-Bulwark Ltd.
OTCMKTS:EBWK
|
$6.55K |
|
China Health Industries Holdings Inc
PINK:CHHE
|
$6.55K |
|
PCCW (TH3B.SG)
STU:TH3B
|
$6.56K |
|
TRAVEL24.COM (TVD6.SG)
STU:TVD6
|
$6.53K |
|
VOCENTO R (VON.SG)
STU:VON
|
$6.53K |
|
FAR EAST HORIZO
MU:F6H
|
$6.53K |
|
HyungjiElite Inc.
KQ:093240
|
$6.52K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cannonau Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from -338,236 to -27,000, a change of 311,236.
- Net income of 338,236 contributed positively to equity growth.
- Other factors decreased equity by 27,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $338.24K | +1252.73% |
| Other Changes | $-27.00K | -100.0% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Cannonau Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | $-0.29 | $0.00 | x |
| 2009-12-31 | $-1.33 | $0.00 | x |
| 2010-12-31 | $64.48 | $0.00 | x |
| 2017-12-31 | $-0.34 | $0.00 | x |
| 2018-12-31 | $-0.34 | $0.00 | x |
| 2019-12-31 | $-1.56 | $0.00 | x |
| 2020-12-31 | $-0.12 | $0.00 | x |
| 2021-12-31 | $-0.10 | $0.00 | x |
| 2022-12-31 | $-0.14 | $0.00 | x |
| 2023-12-31 | $-0.01 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cannonau Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-15.47%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 0.00% | 0.00% | 0.00x | 0.00x | $-29.74K |
| 2009 | 0.00% | 0.00% | 0.00x | 0.00x | $-104.28K |
| 2010 | -154.74% | 0.00% | 0.00x | 1.03x | $-2.09 Million |
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.28 Million |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.28 Million |
| 2019 | 0.00% | -9930.35% | 0.07x | 0.00x | $-66.45K |
| 2020 | 0.00% | -4715.69% | 0.09x | 0.00x | $-71.65K |
| 2021 | 0.00% | -2405.15% | 0.71x | 0.00x | $-123.41K |
| 2022 | 0.00% | -37863.44% | 0.03x | 0.00x | $-52.13K |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $340.94K |
Industry Comparison
This section compares Cannonau Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cannonau Corp (CNNC) | $0.00 | 0.00% | N/A | $6.53K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |